A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer (PHOENIX I)
 
Sponsors and Collaborators
Novartis Pharmaceuticals
 
Contact
Novartis Pharmaceuticals
+1-800 340 6843
 
Investigator
Novartis Pharmaceuticals
 
ClinicalTrial.gov Identifier

NCT01217177